Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma

Syed A. Ali, Verline Justilien, Lee Jamieson, Nicole R Murray, Alan P Fields

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

We report that the protein kinase Cι (PKCι) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKCι activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKCι-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKCι and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKCι-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC. Ali et al. show that in KRAS-mediated lung adenocarcinoma, PKCι controls NOTCH3 expression by phosphorylating ELF3 and driving occupancy at the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the TIC phenotype and combined blockade of PKCι and NOTCH has a synergistic antitumor effect in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)367-378
Number of pages12
JournalCancer Cell
Volume29
Issue number3
DOIs
StatePublished - Mar 14 2016

Fingerprint

Protein Kinase C
Phenotype
Asymmetric Cell Division
Adenocarcinoma of lung
Neoplastic Stem Cells
Oncogenes
Neoplasms
Transcription Factors
Maintenance
Growth

Keywords

  • ELF3
  • KRAS-driven lung adenocarcinoma
  • NOTCH signaling
  • Protein kinase Cι
  • Therapeutic intervention

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma. / Ali, Syed A.; Justilien, Verline; Jamieson, Lee; Murray, Nicole R; Fields, Alan P.

In: Cancer Cell, Vol. 29, No. 3, 14.03.2016, p. 367-378.

Research output: Contribution to journalArticle

@article{cb063ae40ed44c83adf20f3e33edeab1,
title = "Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma",
abstract = "We report that the protein kinase Cι (PKCι) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKCι activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKCι-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKCι and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKCι-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC. Ali et al. show that in KRAS-mediated lung adenocarcinoma, PKCι controls NOTCH3 expression by phosphorylating ELF3 and driving occupancy at the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the TIC phenotype and combined blockade of PKCι and NOTCH has a synergistic antitumor effect in vitro and in vivo.",
keywords = "ELF3, KRAS-driven lung adenocarcinoma, NOTCH signaling, Protein kinase Cι, Therapeutic intervention",
author = "Ali, {Syed A.} and Verline Justilien and Lee Jamieson and Murray, {Nicole R} and Fields, {Alan P}",
year = "2016",
month = "3",
day = "14",
doi = "10.1016/j.ccell.2016.02.012",
language = "English (US)",
volume = "29",
pages = "367--378",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma

AU - Ali, Syed A.

AU - Justilien, Verline

AU - Jamieson, Lee

AU - Murray, Nicole R

AU - Fields, Alan P

PY - 2016/3/14

Y1 - 2016/3/14

N2 - We report that the protein kinase Cι (PKCι) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKCι activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKCι-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKCι and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKCι-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC. Ali et al. show that in KRAS-mediated lung adenocarcinoma, PKCι controls NOTCH3 expression by phosphorylating ELF3 and driving occupancy at the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the TIC phenotype and combined blockade of PKCι and NOTCH has a synergistic antitumor effect in vitro and in vivo.

AB - We report that the protein kinase Cι (PKCι) oncogene controls expression of NOTCH3, a key driver of stemness, in KRAS-mediated lung adenocarcinoma (LADC). PKCι activates NOTCH3 expression by phosphorylating the ELF3 transcription factor and driving ELF3 occupancy on the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the tumor-initiating cell phenotype by regulating asymmetric cell division, a process necessary for tumor initiation and maintenance. Primary LADC tumors exhibit PKCι-ELF3-NOTCH3 signaling, and combined pharmacologic blockade of PKCι and NOTCH synergistically inhibits tumorigenic behavior in vitro and LADC growth in vivo demonstrating the therapeutic potential of PKCι-ELF3-NOTCH3 signal inhibition to more effectively treat KRAS LADC. Ali et al. show that in KRAS-mediated lung adenocarcinoma, PKCι controls NOTCH3 expression by phosphorylating ELF3 and driving occupancy at the NOTCH3 promoter. PKCι-ELF3-NOTCH3 signaling controls the TIC phenotype and combined blockade of PKCι and NOTCH has a synergistic antitumor effect in vitro and in vivo.

KW - ELF3

KW - KRAS-driven lung adenocarcinoma

KW - NOTCH signaling

KW - Protein kinase Cι

KW - Therapeutic intervention

UR - http://www.scopus.com/inward/record.url?scp=84962886830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962886830&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2016.02.012

DO - 10.1016/j.ccell.2016.02.012

M3 - Article

VL - 29

SP - 367

EP - 378

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -